Peer Review History
| Original SubmissionJuly 4, 2020 |
|---|
|
PONE-D-20-20662 Smoking cessation and related factors in middle-aged and older Chinese adults: evidence from a longitudinal study PLOS ONE Dear Dr. Song, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The manuscript is informative and has the potential to make a contribution to the scientific literature. However, major and significant revisions are required for the manuscript to meet the standards for publication. Please attend to the English language deficits of the paper by having it thoroughly edited by a native English language user. Please also attend to the all of the other comments made by the 3 reviewers including the issue of how the percentages of quitters are calculated and defined; the direction of the effect in statements of the results; and the attrition in the sample. Please submit your revised manuscript by November 1, 2020. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Faith B. Dickerson Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Qiu et al report smoking cessation and relapse data from a large, longitudinal study of middle-aged and older smokers in China. The authors evaluated a wide array of demographic, clinical and other variables that might potentially influence cessation and relapse rates. Factors that predicted cessation included geographic location, number of cigarettes smoked per day and time to first cigarette after waking; relapse prediction included age and poor overall health. Although the paper is difficult to follow at times due to language limitations, the study design is straightforward and impressively longitudinal, has a high power sample size and conveys valuable information regarding characterization of the smoking population in China. These data, in turn, may aid public health officials design and manage smoking cessation strategies. Abstract Please indicate in the abstract introduction what percentage of total smokers are those that are middle-aged and older. The abstract (and entire paper) requires a thorough editing to correct word choice, grammar and punctuation. For example, the current word choice in the abstract makes it difficult to ascertain what are exactly the independent predictors for relapse: “being late smoking after waking up every day”? Methods “Ever smokers” are defined as greater than 100. This value seems excessively high. How were health status and self-perceived poor health information defined/extracted? Were data analyses corrected for multiple comparisons? Results Please include at the beginning of table 1 the overall quit rates for 2013 and 2015. The tables and figure are all very informative. The Discussion is comprehensive and appropriate, although again, the paper requires a writing service to correct the language problems. Reviewer #2: This manuscript reports on a secondary analysis with the aim of identifying predictors of quitting and relapse in a sample of 3708 Chinese smokers who participated in a parent study (a general health epidemiology survey) in which they provided data on smoking status at baseline (2011), 2-year(2013), and 4-year (2015) follow ups. This study makes a contribution by focusing on middle-aged smokers (> 45 yrs), which is useful since the over 40 yr old group represents increased health risk of continued smoking. Another novel aspect of the study is the representation of participants from rural China, which adds to the work that has been done in this area. Quit rates were approx. 10% at the 2 year follow up and 17% at the 4-year follow up with 86% of quitters at the 2 year follow up also reporting abstinence at the 4-year follow up. Predictors of quitting in multivariate analysis included older age, higher levels of nicotine dependence, and poorer self-rated health. This replicates other work done internationally as well as work done in China. Suggestions: As reported, I found the quit rates somewhat confusing. Since the authors say they will calculate quit rates as follows: “The quit rate was estimated by dividing the number of quitters at the follow-up survey by the number of smokers at baseline,” I think it would be useful to report the quit rate at 2013 as well as the quit rate at 2015 in terms of the entire sample, (617 self-reported being quit at the 2015 follow up, which would be a quit rate of 16.6% ) rather than just reporting the % quit at 2015 of those who were smoking at 2013. An overall quit rate of 16.6% is reported in the manuscript from 2011-2015, is this meant to be the point prevalence self-reported quit rate at the 2015/4-year follow up? If yes would suggest changing the terminology to reflect this. Between the 2 and 4 year follow-ups, a continuous quit rate of 7.4% (275/3708) was reported, however, was continuous quit rate actually assessed or could this be capturing people who happen to report being quit at the two assessments, but have not been continuously quit? If the latter is true, needs to be mentioned as a limitation that could be overestimating continuous quit rates. Also, although this does represent the “continuous” quit rate in the total sample, would suggest the authors emphasize the high % of quitters who maintained abstinence (86.7%) as well as noting, as they do, the relapse rate of 13.1% . I do not understand what is meant here: “To facilitate the comparison with findings from different studies, the annual quit rate was estimated based on the quit rates for different follow-up years and an assumption of constant rates of still smoking during the follow-up.” Two limitations that should be emphasized are the reliance on self-report data and on a completer analysis. Reliance on self-report data is mentioned in the discussion, but deserves more attention, particularly whether there are reasons people might lie about their smoking status (in the US, for example, people lie about this to health insurers because they do not want their rates to be higher). Statistical tests should be done to evaluate differences between those who completed both follow-ups to those who did not. An alternative to age started smoking and number of cigs/day as separate predictor variables would be to create a composite variable “pack years.” Did any unique predictors emerge to predict “continuous quit?” (Or are these all just the opposite of the predictors of relapse?) Minor comments: Throughout manuscript, when citing predictors of quitting, specify direction (e.g., age) of the effect “The starting smoking age” should be rephrased “Age started smoking” A few grammatical errors in this statement in the Abstract: having less smoking number use, longer time to first cigarette upon waking. Independent predictors of staying quit in 2015 included being younger, being late smoking after waking up every day, having shorter smoking age Reviewer #3: This is a study that examined smoking cessation, smoking relapse and related factors among middle-aged and older(≧45) smokers based on a secondary analysis of the dataset of the the China Health and Retirement Longitudinal Study (CHARLS). Here are some comments that may be helpful to improve the quality of this manuscript. -The language needs to be further edited by native English speakers. Abstract: -The statistics of independent correlates of smoking quit, and staying quit should be provided in both the Abstract and the main text, such as p values, and ORs with 95%CI. Methods: -Statistics: Please specify which type of multiple logistic regression anayses were performed. Stepwise or other types? One- or two-sided tests? Clarify how to select the independent variables? Results: -Table 1: add (years) for Age. Discussion: -Strengths/Limitations: This is not a national survey. -All Table/Figures should appear after the ref list, rather than in the text. This is general knowledge when drafting a manuscript. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Corinne Cather Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-20662R1 Smoking cessation and related factors in middle-aged and older Chinese adults: Evidence from a longitudinal study PLOS ONE Dear Dr. Song, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please make the following changes so that your manuscript will be acceptable for publication. Note – that the comments below are with reference to the tracked changes resubmitted version
Please submit your revised manuscript by November 1, 2020. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Faith B. Dickerson Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-20-20662R2 Smoking cessation and related factors in middle-aged and older Chinese adults: Evidence from a longitudinal study PLOS ONE Dear Dr. Song, Thank you for submitting your manuscript to PLOS ONE and for the detailed changes that you have made. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please note below a few minor revisions, most related to English-language usage, that are required before the manuscript is fully acceptable. These notes are with reference to the CLEAN version of the resubmitted manuscript. Page 5, line 81 – should be “participants” Page 7 – line 110 – should be “point prevalence” [add “prevalence”]. Here and elsewhere - page 16 - line 227. Page 8, line 135 – delete “the” near end of the line Page 11, row 152 – add “the” to “not living in the northeast region” Page 12, line 162 – add “the: to “relapse in the 317 quitters” Page 15, line 206 – typo at end of line – “the” Page 15 – line 216 – add “had” to “…and who had perceived poor health” Page 16 – line 223 – isn’t it two waves of follow-up not three? Please correct here and elsewhere Please submit your revised manuscript by November 1, 2020. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Faith B. Dickerson Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Smoking cessation and related factors in middle-aged and older Chinese adults: Evidence from a longitudinal study PONE-D-20-20662R3 Dear Dr. Song, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Faith B. Dickerson Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-20662R3 Smoking cessation and related factors in middle-aged and older Chinese adults: Evidence from a longitudinal study Dear Dr. Song: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Faith B. Dickerson Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .